Outcomes in patients undergoing periprocedural interruption of warfarin or direct oral anticoagulants

This publication has 25 references indexed in Scilit:

• The HAS-BLED Score Has Better Prediction Accuracy for Major Bleeding Than CHADS2 or CHA2DS2-VASc Scores in Anticoagulated Patients With Atrial Fibrillation
  JACC, 2013
• Warfarin use in atrial fibrillation patients at low risk for stroke: analysis of the Michigan Anticoagulation Quality Improvement Initiative (MAQI2)
  Journal of Thrombosis and Thrombolysis, 2013
• How I treat anticoagulated patients undergoing an elective procedure or surgery
  Blood, 2012
• Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin
  Circulation, 2012
• Relation of the HAS-BLED Bleeding Risk Score to Major Bleeding, Cardiovascular Events, and Mortality in Anticoagulated Patients With Atrial Fibrillation
  Circulation: Arrhythmia and Electrophysiology, 2012
• Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome
  New England Journal of Medicine, 2011
• Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial
  European Heart Journal, 2011
• A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
  Chest, 2010
• Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
  Chest, 2010
• Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients
  Journal of Thrombosis and Haemostasis, 2005